Discovery Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Discovery Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,232,929	Closed	-$20.8M	–	72
2017 Q2	$20.8M	Sell	1,232,929 -1,787,173	-59%	-$27.2M	0.51%	40
2017 Q1	$40.3M	Sell	3,020,102 -1,448,266	-32%	-$22.7M	0.75%	50
2016 Q4	$67.2M	Sell	4,468,368 -33,547	-0.7%	-$443K	1.13%	36
2016 Q3	$52.6M	Hold	4,501,915	–	–	1.12%	36
2016 Q2	$48.6M	Hold	4,501,915	–	–	1.12%	35
2016 Q1	$41.6M	Hold	4,501,915	–	–	0.6%	47
2015 Q4	$66.8M	Sell	4,501,915 -96,000	-2%	-$1.61M	0.79%	44
2015 Q3	$75.5M	Buy	4,597,915 +501,500	+12%	+$10.3M	0.84%	46
2015 Q2	$93.4M	Buy	4,096,415 +1,194,202	+41%	+$23.8M	1.1%	29
2015 Q1	$44.1M	Buy	2,902,213 +250,000	+9%	+$3.25M	0.5%	57
2014 Q4	$31.9M	Buy	2,652,213 +274,700	+12%	+$3.14M	0.33%	72
2014 Q3	$27M	Hold	2,377,513	–	–	0.3%	60
2014 Q2	$28.7M	Buy	2,377,513 +350,000	+17%	+$4.13M	0.27%	74
2014 Q1	$23.6M	Buy	2,027,513 +100,000	+5%	+$1.69M	0.17%	97
2013 Q4	$34.1M	Hold	1,927,513	–	–	0.25%	72
2013 Q3	$27.7M	Buy	1,927,513 +909,000	+89%	+$13.9M	0.24%	66
2013 Q2	$15.3M	Buy	+1,018,513	New	+$13.4M	0.16%	77

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Discovery Capital Management's MNTA Position: Q3 2017 in Review

Discovery Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2017, closing a stake of 1,232,929 shares — an estimated $20.8M sold.

Discovery Capital Management first reported a position in MNTA in Q2 2013 and held it in 17 quarters. The position peaked at $93.4M in Q2 2015. 158 funds tracked by Wall St. Rank hold MNTA as of Q3 2017.

Discovery Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
Discovery Capital Management sold 1,232,929 Momenta Pharmaceuticals, Inc. shares in Q3 2017, an estimated $20.8M.
Discovery Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
Discovery Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $93.4M in Q2 2015.
158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2017.

Based on Discovery Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.